Gilead Sciences (GILD) Current Deferred Tax Assets (2016)
Gilead Sciences' Current Deferred Tax Assets history spans 8 years, with the latest figure at $857.0 million for Q4 2016.
- For Q4 2016, Current Deferred Tax Assets rose 3.5% year-over-year to $857.0 million; the TTM value through Dec 2016 reached $857.0 million, up 3.5%, while the annual FY2016 figure was $857.0 million, 3.5% up from the prior year.
- Current Deferred Tax Assets reached $857.0 million in Q4 2016 per GILD's latest filing, up from $762.0 million in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $894.0 million in Q3 2015 to a low of $193.9 million in Q1 2012.
- Average Current Deferred Tax Assets over 5 years is $501.1 million, with a median of $385.6 million recorded in 2014.
- Peak YoY movement for Current Deferred Tax Assets: tumbled 30.2% in 2012, then surged 132.46% in 2015.
- A 5-year view of Current Deferred Tax Assets shows it stood at $262.6 million in 2012, then rose by 26.03% to $331.0 million in 2013, then soared by 53.47% to $508.0 million in 2014, then surged by 62.99% to $828.0 million in 2015, then rose by 3.5% to $857.0 million in 2016.
- Per Business Quant, the three most recent readings for GILD's Current Deferred Tax Assets are $857.0 million (Q4 2016), $762.0 million (Q3 2016), and $835.0 million (Q2 2016).